CEO-TWO
- Product NDC
- 0283-1023
- 11-digit product format
- 002831023
- Labeler code
- 0283
- Product ID
- 0283-1023_42e0774e-b617-290d-e063-6394a90a199e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Laxative
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Beutlich Pharmaceuticals, LLC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-10-15
- Substance
- POTASSIUM BITARTRATE; SODIUM BICARBONATE
- Active strength
- .9; .6 g/5.7g; g/5.7g
- Pharmacologic classes
- Alkalinizing Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEO-TWO
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POTASSIUM BITARTRATE | .9 g/5.7g |
| SODIUM BICARBONATE | .6 g/5.7g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NPT6P8P3UU | Internal UNII lookup |
| 8MDF5V39QO | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08670636-5795-4db0-e063-6294a90afa4b | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0283-1023-00 | CEO-TWO | 5.7 g in 1 DOSE PACK | SUPPOSITORY | 5.7 | 3 | |
| 0283-1023-02 | CEO-TWO | 2 in 1 BOX | SUPPOSITORY | 2 | 3 | |
| 0283-1023-36 | CEO-TWO | 6 in 1 BOX | SUPPOSITORY | 6 | 3 | |
| 0283-1023-54 | CEO-TWO | 54 in 1 BOX | SUPPOSITORY | 54 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0283-1023-02 | EA - Each | 0283-1023 | d7803fbb-22f6-4acb-bdd2-b3da0cb16667 | 1 | 2025-08-11 |
| 0283-1023-36 | EA - Each | 0283-1023 | 299afce1-70d3-4bcd-88c0-094182298613 | 1 | 2025-08-11 |
| 0283-1023-54 | EA - Each | 0283-1023 | aab567b9-183d-4296-a18e-a6c0a9c6cd3e | 1 | 2025-08-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fleet | BISACODYL | C.B. Fleet Company, Inc. | 324e61eb-8f6b-48d7-85c2-b1b5642691c9 | 2025-06-23 | Warnings | M007 |
| Saline Laxative | SODIUM PHOSPHATE | Walgreen Company | fb260df0-7bda-4299-84a5-44c8f9447798 | 2025-06-18 | Warnings | M007 |
| De La Cruz Castor Oil | CASTOR OIL | DLC Laboratories, Inc. | 22fbad2e-e9fa-46ba-8617-ad79483cbe9a | 2025-06-13 | Warnings | M007 |
| Prolaxa | DOCUSATE SODIUM 250MG | Terrain Pharmaceuticals | 32610e42-f352-09fd-e063-6394a90abff6 | 2025-06-12 | Warnings | M007 |
| DOCUZEN | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Village Pharma | 29102014-9b0e-4899-958d-83111f94a612 | 2025-06-01 | Warnings | M007 |
| MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | Power Health, Products, Inc. | 364b558b-69b5-bfa4-e063-6294a90acd0c | 2025-05-29 | Warnings | M007 |
| MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | Power Health, Products, Inc. | 364bc4f5-6337-6c89-e063-6394a90a12ab | 2025-05-29 | Warnings | M007 |
| SENNA | SENNOSIDES | AARNA USA INC. | 364d4dfc-a089-1a27-e063-6394a90ad77b | 2025-05-29 | Warnings | M007 |
| MILK OF MAGNESIA CHERRY | MAGNESIUM HYDROXIDE | Power Health, Products, Inc. | 3634b4e4-4fea-9428-e063-6394a90a6ad9 | 2025-05-28 | Warnings | M007 |
| MILK OF MAGNESIA ORIGINAL | MAGNESIUM HYDROXIDE | ATLANTIC BIOLOGICALS CORP. | 30fb7b5e-56a3-423e-ae57-432006b54fff | 2025-05-23 | Warnings | M007 |
| Senna Liquid | SENNA LIQUID | Belleview Biosciences | 35d5f217-b101-3cd8-e063-6394a90adccd | 2025-05-23 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | Walgreens | 816c82f8-0fa5-4b22-a226-e8f22f3eaa1d | 2025-05-23 | Warnings | M007 |
| Senna Laxative | SENNA | PD-Rx Pharmaceuticals, Inc. | 2b03d07c-ea4f-4663-bcc3-20ebdf83b7aa | 2025-05-21 | Warnings | M007 |
| Senna | SENNOSIDES | Akron Pharma Inc. | 55ce3969-d7a6-49c4-8c13-d95690efc1a6 | 2025-05-16 | Warnings | M007 |
| Saline Enema | SODIUM PHOSPHATE MONOBASIC, SODIUM PHOSPHATE DIBASIC | Dynarex Corporation | 7c7b68af-4ef2-4f84-9279-9f7a91c8d9c5 | 2025-05-14 | Warnings | M007 |
| Bisacodyl | BISACODYL | Rising Pharma Holdings, Inc. | 03429da4-1ce9-4789-bf54-ce1b3215b013 | 2025-05-13 | Warnings | M007 |
| COLACE EXTRA STRENGTH STOOL SOFTNER | DOCUSATE SODIUM | Atlantis Consumer Healthcare Inc. | 34e06b05-64a5-4b3e-af38-cdcd7c1d521b | 2025-05-01 | Warnings | M007 |
| Senna | SENNOSIDES | PAI Holdings, LLC dba PAI Pharma | 7c28ffb8-149f-4a5a-ab98-dfa7b3b0f6ed | 2025-04-28 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Belleview Bio Science | 335f41d7-5c22-7c17-e063-6294a90a8f28 | 2025-04-22 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | e5028f6d-d33d-47a9-8453-00af5cdf59a6 | 2025-04-20 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 636188 | CEO-TWO 0.9 GM / 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository [Ceo-Two] | SBD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository | SCD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0283-1023-00 | 00283102300 | 5.7 g in 1 DOSE PACK | 5.7 g | Historical | |||
| 0283-1023-02 | 00283102302 | 2 DOSE PACK in 1 BOX (0283-1023-02) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 2 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-36 | 00283102336 | 6 DOSE PACK in 1 BOX (0283-1023-36) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 6 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-54 | 00283102354 | 54 DOSE PACK in 1 BOX (0283-1023-54) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 54 dose pack | 2023-10-15 | No | No | Current |